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Abstract: Sensitive cell detection by magnetic resonance imaging (MRI) is an important tool 
for the development of cell therapies. However, clinically approved contrast agents that allow 
single-cell detection are currently not available. Therefore, we compared very small iron oxide 
nanoparticles (VSOP) and new multicore carboxymethyl dextran-coated iron oxide nanoparticles 
(multicore particles, MCP) designed by our department for magnetic particle imaging (MPI) 
with discontinued Resovist® regarding their suitability for detection of single mesenchymal stem 
cells (MSC) by MRI. We achieved an average intracellular nanoparticle (NP) load of .10 pg 
Fe per cell without the use of transfection agents. NP loading did not lead to significantly 
different results in proliferation, colony formation, and multilineage in vitro differentiation 
assays in comparison to controls. MRI allowed single-cell detection using VSOP, MCP, and 
Resovist® in conjunction with high-resolution T2*-weighted imaging at 7 T with postprocessing 
of phase images in agarose cell phantoms and in vivo after delivery of 2,000 NP-labeled MSC 
into mouse brains via the left carotid artery. With optimized labeling conditions, a detection 
rate of ~45% was achieved; however, the experiments were limited by nonhomogeneous NP 
loading of the MSC population. Attempts should be made to achieve better cell separation for 
homogeneous NP loading and to thus improve NP-uptake-dependent biocompatibility studies 
and cell detection by MRI and future MPI. Additionally, using a 7 T MR imager equipped with 
a cryocoil resulted in approximately two times higher detection. In conclusion, we established 
labeling conditions for new high-relaxivity MCP, VSOP, and Resovist® for improved MRI of 
MSC with single-cell sensitivity.
Keywords: magnetic field microdistortions, single-cell imaging, mesenchymal stem cells, 
VSOP, MCP, Resovist®
Introduction
Many clinical studies (clinicaltrials.gov) exploit the immunomodulatory and 
regenerative capacities1–6 of multipotent mesenchymal stem cells (MSC).7,8 However, 
the role of MSC in regenerative medicine is not fully understood and their direct or 
paracrine effects remain to be clarified.9,10 In addition, parameters such as cell injec-
tion site and dose, cell survival, and cell engraftment require optimization in some 
disease models.11–15
For these reasons, monitoring of cell therapies is of high clinical relevance 
and, despite several challenges to overcome, magnetic resonance imaging (MRI) 
continues to be the method of choice, offering high tissue penetration depth and 
spatial resolution in comparison with alternative methods.16,17 Drawbacks of MRI 
such as low specificity due to unspecific signal from phagocytosed injected cells, 
dead cells, or local hemorrhage14,18,19 have been shown to limit the use of MRI for cell 
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imaging in longitudinal studies, and considerable research 
efforts are devoted to finding alternative/complementary 
methods.19,20
With their strong negative contrast in T2- or T2*-weighted 
MR images, superparamagnetic iron oxide nanoparticles 
(NPs) are the most common contrast agents used to label 
cells for MRI cell tracking. The two most widely used NPs 
were initially developed and approved by the US Food and 
Drug Administration (FDA) for liver imaging.21 These are 
dextran-coated Endorem/Feridex® (AMAG Pharmaceuticals, 
Inc., Waltham, MA, USA), with hydrodynamic particle sizes 
ranging from 80 to 100 nm, and carboxymethyl dextran-
coated ferucarbotran (Resovist®; Schering AG – now Bayer 
Pharma AG, Berlin, Germany) with a hydrodynamic particle 
size by a number of 24–44 nm.14,22,23 However, these prod-
ucts are no longer on the market.12,24 Alternatively, FDA-
approved ferumoxytol/Feraheme (AMAG Pharmaceuticals 
Inc), developed to treat iron deficiency anemia,25 has 
been used for MRI,26 and cell labeling has been achieved 
after cell incubation with nanocomplexes of ferumoxy-
tol-heparin-protamine. To the best of our knowledge, the 
most sensitive MRI detection has been accomplished for 
1,000 ferumoxytol-labeled cells after intracerebral implan-
tation when cells were labeled with 2.2 pg Fe per cell.27–30 
However, no attempts have been made to visualize single 
cells with any of these approaches. Alternatively, Bulte31 
proposed in vivo labeling of MSC obtained by bone marrow 
(BM) aspiration from rats after prior IV injection with feru-
moxytol. The authors reported an average NP load of 4.3 pg 
Fe per cell, and MRI was achieved in vivo after implantation 
of 100,000 cells embedded in hydrogel scaffolds in rats 
with osteochondreal defects.31 Despite these results and 
the relevance of exploiting the potential of ferumoxytol 
to label MSC, the NP load per cell might not be sufficient 
for single-cell detection, as we discuss later. The limit of 
detection that can be achieved with ferumoxytol-labeled 
MSC remains to be determined.
Alternative contrast agents commercially available for 
research, such as Molday ION EverGreen (BioPAL Inc, 
Worcester, MA, USA; single core with a carboxydextran shell), 
FeraTrack (Miltenyi Biotec, Surrey, UK), and Dragon Green-
encapsulated Magnetic Polymers (Bangs Beads; Stratech 
Scientific Ltd, Suffolk, UK; micrometer-sized polysterene 
matrix formed by several magnetic cores), are compared else-
where for MSC labeling.32 Overall, these contrast agents are 
reported to achieve biocompatible intracellular MSC labeling, 
with an uptake of 5–9 pg [Fe] per cell.17 More recently, the 
cellular uptake of 69.1 pg Fe per hMSC (human MSC) has 
been reported for citrate-coated superparamagnetic iron oxide 
nanoparticles from MagneticFluids (Berlin, Germany).27
Although many studies have investigated MSC labeling 
for MRI, the results are difficult to compare due to the wide 
range of NPs and methodologies used to label cells.14,33–35 One 
of the most commonly used methods to enhance NP uptake 
by nonphagocytic cells is to use polycationic transfection 
agents (TAs) such as protamine sulfate (PS) (FDA approved) 
to form positively charged NP complexes, which penetrate 
cell membranes more easily.36,37 However, using TAs in 
human cell therapies will require additional FDA validation 
of the NP–TA, as previously suggested for the Feridex®–PS 
complex;38 moreover, simplified protocols would facilitate 
bench-to-bedside translation.
Electrostatically stabilized very small iron oxide par-
ticles (VSOP), with a hydrodynamic diameter of only 7 nm, 
combine high cellular uptake with low cytotoxicity due to 
their biocompatible citrate coating.39–44 Earlier produced as 
VSOP-C184 (Ferropharm, Teltow, Germany),45 these have 
been used for MSC labeling and found to have a detection 
limit of 40,000 cells in an 11.7 T MRI setting.46 These NPs 
are no longer available. In the past decade, VSOP have been 
further developed in our laboratory for magnetic resonance 
angiography and MRI of atherosclerotic plaques.47–51 They 
have been tested for MSC labeling and MRI detection with 
single-cell sensitivity.
Increased MRI sensitivity at the cellular level has been 
achieved using postprocessed phase images that visualize 
magnetic field microdistortions (MFMDs) caused by NP-
labeled cells in the magnetic field of an MR scanner. The 
cells visualized as dipole figures in phase images acquired 
with T2*-weighted pulse sequences allow detection with 
improved sensitivity and selectivity of the cells. Moreover, 
this procedure can be used to predict the iron load of 
VSOP-labeled HeLa cells based on frequency maps52 and of 
monocytes/macrophages labeled with encapsulated Feridex 
or micrometer-sized iron oxide particles based on particle 
magnetic moments.53
The relevance of MRI in cell therapy monitoring is 
broadly recognized.54–58 We think that improved MRI-based 
cell detection with single-cell sensitivity will provide a 
useful tool for establishing cell injection doses and the best 
injection site and for monitoring biodistribution without the 
need for administration of large cell numbers in developing 
new cell therapies.
In this study, we investigate optimized intracellular 
labeling methods of MSC for MRI single-cell detection using 
multicore superparamagnetic carboxymethyl dextran-coated 
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iron oxide nanoparticles (MCP) and citrate-coated VSOP, 
both developed in the Department of Radiology, Charité – 
Universitätsmedizin Berlin, and compare them with 
Resovist®.
Methods
Nanoparticle analysis
Relaxivities (T1 and T2) were measured with a Minispec MQ 
40 time-domain nuclear magnetic resonance spectrometer at 
40°C, 40 MHz, and 0.94 T (Bruker Corporation, Billerica, 
MA, USA). Relaxation coefficients R
1
 and R
2
 were obtained 
by linear fitting of T1 and T2 relaxation rates and normalized 
to iron concentrations.
Hydrodynamic diameters, polydispersity index, and zeta 
potentials were determined using a Zetasizer Nano ZS par-
ticle analyzer (Malvern Instruments, Malvern, UK) at 1 mmol 
Fe/L (NP concentration). Zeta potentials were measured for 
unformulated particles in 10 mM NaCl solution until constant 
values were reached.
cell labeling
Primary MSC from murine (C57BL/6) BM (Thermo Fisher 
Scientific, Waltham, MA, USA) were maintained for up to 
ten passages with Dulbecco’s Modified Eagle’s Medium 
(DMEM) F-12 (Thermo Fisher Scientific) with 10% fetal 
bovine serum (FBS) as growth medium at 5,000 cells/cm2, 
avoiding confluence. Cells were passaged at standardized cell 
density (15,000 cells/cm2), followed by overnight recovery 
in growth medium. Cells were labeled with Resovist®, MCP, 
or VSOP (variant of VSOP doted with 0.66 mol% europium 
for laser ablation inductively coupled plasma mass spectrom-
etry [LA-ICP-MS] detection in histology, Scharlach et al, 
accepted for publication in Journal of Biomedical Nano-
technology) using NP-labeling concentrations of 0.2 mM Fe 
with TA or 2 mM Fe without TA in growth medium without 
phenol red and with 1% FBS by incubation for 4 hours or 
24 hours at 37°C.
The ratio of Resovist® or MCP to protamine sulfate (PS) 
as TA was optimized to increase NP uptake and to limit 
NP aggregation. The optimal NP:PS ratio was 0.2 mM Fe 
(denoted as 1×) to 12 µg/mL PS (denoted as 1× PS). VSOP 
were incubated without TA for both concentrations, 0.2 mM 
Fe (1×) and 2 mM (10×). NP incubation with cells was fol-
lowed by three washing steps using phosphate-buffered saline 
(PBS), extracellular matrix (ECM) disruption by incubation 
with TrypLe (Thermo Fisher Scientific) for 5 minutes at 37°C 
and cell passage at 15,000 cells/cm2 either into new culture 
flasks or into chamber slides. Before further use, cells were 
left in complete growth medium for overnight recovery and 
NP internalization at 37°C.
Cell collection was followed by cell quantification, 
controlling viability and aggregation, on a CASY Model TT 
(Innovatis, Hoffman-La Roche Ltd., Basel, Switzerland).
Iron stain
Labeled cells incubated in adherent chamber slides (Thermo 
Fisher Scientific, Waltham, MA, USA) were washed 3× with 
PBS and fixed in zinc (BD Pharmingen, Franklin Lakes, 
NJ, USA) (1:1 dH
2
O) for 20 minutes at room temperature 
(RT). Zinc removal was followed by iron staining using 
the standard Prussian Blue protocol. In brief, cells were 
incubated with 1% potassium hexacyanoferrate (II) solu-
tion (Sigma-Aldrich Co, St Louis, MO, USA) (5 minutes 
at RT) and 1% potassium hexacyanoferrate with 1% HCl 
(20 minutes at RT), followed by 3× washing with dH
2
O and 
counterstained with nuclear red solution (Merck & Co, Inc, 
Whitehouse Station, NJ, USA) for 30 seconds. Slides were 
washed 3× and dehydrated by dipping into 70%, 80%, 96%, 
and 100% ethanol solutions for 30 seconds each, followed 
by 5 minutes’ treatment with xylol and 5 minutes’ drying, 
and then covered with Pertex (Medite, Burgdorf, Germany). 
Photomicrographs were obtained on an Axio Observer.Z1 
Zeiss microscope equipped with Zen 2012 imaging software 
(Carl Zeiss microscopy GmbH, Oberkochen, Germany).
Iron quantification
Fractions of cells (50,000 cells) used for MRI phantoms were 
also used for iron quantification applying the colorimetric 
phenanthroline method.59,60 The method was adapted for 
cell pellets stored at −20°C. Cell pellets were disrupted by 
1 hour ultrasound exposure, and the incorporated iron was 
dissolved in 5 µL concentrated HCl. Dissolved iron in HCl 
was diluted in water (1:50) and treated at the ratio of 2:7:1 
with phenanthroline and hydroxylamine hydrochloride for 
15 minutes at RT. Developed colorimetric reaction was 
measured photometrically at 510 nm to quantify iron.
cell biocompatibility
NP-labeled and unlabeled MSC were compared using the 
following assays:
Population doubling time
Population doubling time (PDT) was assessed as described 
elsewhere.61 In brief, MSC labeled with NPs were plated 
into six-well plates at 2,000 cells per well with complete 
growth medium and medium was changed every 2 days. 
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The living cell population was assessed by automatic cell 
counting with the CASY Model TT, every 2 days from Day 2 
to Day 10. The following formula was used to calculate the 
PDT: PDT = T × ln2/ln(N
t
/N
0
), where N
0 
= initial cell number, 
N
t 
= end point cell number, and T = time interval.
Fibroblast colony-forming unit assay
After completion of the NP-labeling protocol, MSC cultures 
with no more than 70%–80% confluence were harvested with 
TrypLe (Thermo Fisher Scientific) as described by Gibco® 
Mouse MSC Catalog number S1502-100. The fibroblast col-
ony-forming unit (CFU-F) assay was performed as described 
elsewhere,62 with some modifications. In brief, MSC were 
plated in six-well plates with 16 cells per well (Falcon, 
Corning Science Tewksbury, MA, USA) in complete growth 
medium. The cells were cultured for 14 days at 37°C in a 
humidified incubator with 5% CO
2
, with medium exchange 
every 2 days. Colonies were washed with PBS and stained 
with 0.5% crystal violet (Sigma-Aldrich Co.) in methanol for 
5 minutes. The wells were washed twice in distilled water, 
and the number of colonies was determined. Colonies ,2 mm 
in diameter and faintly stained were ignored.
Differentiation assays
All differentiation assays were performed with MSC not older 
than passage 4 and after 48-hour incubation in MSC basal 
medium (Thermo Fisher Scientific; alpha-minimum essential 
media with GlutaMAX-I, 10% MSC-qualified FBS, and gen-
tamicin). Differentiation protocols were performed as described 
by Gibco® Mouse MSC Catalog number S1502-100.
adipogenesis assay
MSC were plated at 20,000 cells/cm2 in 12-well plates (Costar 
Corning Incorporated, Corning, NY, USA) for induction of 
adipogenic differentiation as described by provider (Thermo 
Fisher Scientific). In brief, after 48-hour incubation in MSC 
Basal Medium (Thermo Fisher Scientific), the medium was 
replaced by adipogenic differentiation medium (StemPro® 
Adipocyte Differentiation Basal Medium 1×, StemPro® 
Adipogenesis supplement 1×, and gentamicin (10 mg/mL). 
This medium was renewed twice a week over the incubation 
period of 11–14 days. Adipogenesis was studied by staining 
using the oil red standard stain procedure with some modi-
fications to achieve costaining for iron. Twelve-well plates 
were washed 3× with PBS and cells were fixed for 15 minutes 
at RT with zinc (1:10) in dH
2
O,63 washed 2× with dH
2
O and 
processed for Oil Red O staining. For staining, wells were 
rinsed with 60% isopropanol and 0.5% (w/v) Oil Red O 
(Sigma-Aldrich Co) stock solution was prepared. Fat deposits 
were stained by incubation with Oil Red O for 15 minutes. 
Finally, the cells were rinsed with 60% isopropanol and 
stained for iron as described earlier.
chondrogenesis
Labeled MSC in monolayer were trypsinized and trans-
ferred into 15 mL Falcon tubes at a concentration of 
20,000 cells/2 mL to stimulate micromass formation by 
centrifugation for 4 minutes at 800× g. Micromasses were 
incubated at 37°C and 5% CO
2
 in MSC Basal Medium 
(Thermo Fisher Scientific), followed by detachment from 
the bottom by gentle flicking. Chondrogenic differentiation 
was then induced by incubation with Chondrogenic Dif-
ferentiation Medium as described by supplier (StemPro® 
differentiation kits; Thermo Fisher Scientific) for 20 days 
with medium change twice a week. Condensates were col-
lected, gently washed in PBS, and frozen in cryomolds with 
OCT Cryomedium (Tissue Tek Sakura Finetek Europe B.V, 
Alphen aan den Rijn, the Netherlands) and stored at −20°C. 
Cryosections of 5–10 µm thickness were used to stain 
glycosaminoglycans with a modified Alcian Blue protocol 
(www.ihcworld.com). Cryosections were dried at RT and 
fixed with 4% paraformaldehyde for 10 minutes, followed by 
several washes. Then, the sections were stained with Alcian 
Blue, pH 1.0 (1 N HCl) for 20 minutes and counterstained 
with filtered 1% Neutral Red (Applichem GmbH, Darmstadt 
Germany) in glacial acetic acid.
Osteogenesis
MSC were plated at 5,000 cells/cm2 in 12-well plates for 
osteogenic differentiation as described in the supplier’s 
protocol (StemPro® differentiation kits, Thermo Fisher 
Scientific). In brief, after 48 hours’ incubation at 37°C and 
5% CO
2
 in MSC Basal Medium (Thermo Fisher Scientific), 
the medium was replaced with osteogenic differentiation 
medium (StemPro® differentiation kits; Thermo Fisher 
Scientific) for 11–14 days, with medium change twice a 
week. Osteogenesis was stained using the von Kossa pro-
tocol. Briefly, cells were fixed with 1% paraformaldehyde 
for 15 minutes, washed twice with dH
2
O, and dried at RT. 
This was followed by incubation with 1% silver nitrate under 
ultraviolet lamp exposure for 20 minutes, washed thrice with 
dH
2
O, then incubated for 5 minutes with 5% sodium thiosul-
fate, and lastly washed thrice with dH
2
O and counterstained 
for 5 minutes with Nuclear red (Merck).
cell phantoms for MrI
Agarose cell phantoms were prepared as previously described 
by our group.52 Three nuclear magnetic resonance tubes were 
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placed in a 15 mL Falcon tube filled with agarose (1w%, w/w). 
Nuclear magnetic resonance tubes were used to immobilize 
cells in 1 mL of 0.5% m/w degassed low-melting agarose. Each 
phantom consists of three tubes with 1,000 or 2,000 labeled 
cells per milliliter and one tube with 2,000 unlabeled cells.
Delivery of iron-labeled Msc to mouse 
brain
Male 6-week-old C57BL/6 mice were anesthetized with 3% 
isoflurane in a 70:30 nitrous oxide: oxygen mixture, main-
taining a core body temperature of 37.2°C±0.8°C using an 
automated heat blanket.
Mice were placed in the supine position. The neck was 
shaved, cleaned, and a midline incision was made. The left 
sternomastoid muscle was retracted to expose the left carotid 
artery (CA). A silk suture was tied around the CA below the 
bifurcation into the internal and external carotid arteries (ICA 
and ECA, respectively). A loose suture was placed around the 
ECA and secured externally. Another loose suture was placed 
on the ICA and a microclip placed directly above it. A small 
incision was made in the CA and a plastic cannula (diameter 
200 µm) connected to a syringe was inserted into the incision. 
The cannula was advanced to the ICA and secured with the 
loose ICA thread and the thread around the CA.
After MRI and infusion of cells, the cannulated CA 
was ligated around the incision site. All other threads were 
removed, muscles and glands guided back into place, and the 
incision sutured. Bupivacaine gel was applied to the sutured 
wound prior to recovery, and the animals were injected with 
1.5 mL of sterile saline for rehydration. All animal experi-
ments were approved by Das Landesamt für Gesundheit und 
Soziales (LaGeSo) animal license G0453/12.
Animals were sacrificed under anesthesia after MRI, and 
brains were extracted and fixed in zinc solution (1:10). Animal 
experiments were approved by the local authority (Landesamt 
für Gesundheit und Soziales, Berlin) and were performed 
according to institutional guidelines (BGBl. I S. 2178).
Magnetic resonance imaging
All in vitro phantoms and mouse brains were imaged on a 7 T 
Pharmascan MRI scanner (Bruker) with a 35 mm-diameter 
mouse volume resonator coil or 20 mm diameter mouse head 
coil. In vitro phantoms were imaged with a fast low-angle 
shot (FLASH) sequence (flip angle [FA]: 9°, echo time [TE]: 
5.4 milliseconds, repetition time [TR]: 20 milliseconds) 
acquired with a 192×256 matrix, 82 µm in-plane resolution, 
and a slice thickness of 400 µm.
In vivo imaging was performed using FLASH 3D 
sequences with a 256×256 matrix, 82 µm in-plane resolution, 
FA of 30°, slice thickness of 350 µm, TE 5.4 milliseconds, and 
TR 400 milliseconds.
Image postprocessing was performed as previously 
published by our group.52
Additional in vitro phantoms were imaged with a 7 T 
BioSpec 70/20 MRI system (Bruker), equipped with a 
CryoProbe™ coil. Imaging was done with a susceptibility-
weighted imaging-FLASH sequence acquired with a 
256×256 matrix, 80 µm in-plane resolution, FA of 30°, 
TE of 18 milliseconds, TR of 800 milliseconds, and a slice 
thickness of 200 µm.
Total detected cell numbers were calculated based on the 
volume of at least 12 MR image slices per agarose phantom.
Ex vivo iron quantification by magnetic 
particle spectroscopy in mouse brains
Murine brains with Resovist®-, MCP-, or VSOP-labeled 
MSC were dissected, washed in cold PBS, and maintained 
in formalin at 4°C until further use. All preparations for 
magnetic particle spectroscopy (MPS) were carried out with 
a ceramic dissecting set to prevent false results through pos-
sible abrasion of magnetic material, as previously described 
by Scharlach et al.51 Mouse brains were longitudinally cut 
in two halves (right and left). Each half was fit into 0.1 mL 
polymerase chain reaction (PCR) tubes for MPS.
For MPS measurement, the sample was exposed to a 
strong sinusoidal oscillating magnetic field (B
excite
 =25 mT) at a 
drive frequency, f
excite
, of 25 kHz. The magnetization response 
was detected for 10 seconds by a pickup coil (sensitivity: 
5×1012 Am2) tightly enclosing the tip region of the PCR tube. 
Filtering and gradiometric assembly of the pickup coil ensured 
that the fundamental excitation frequency was heavily sup-
pressed. Due to the nonlinear magnetization response of mag-
netic NPs, the spectral components of the Fourier-transformed 
response signal have distinct amplitudes at odd multiples of 
the drive frequency ( f
excite
) constituting the MPS spectrum. 
All MPS measurements were performed at 37°C.
For quantification of magnetic NP uptake, the moment of 
the third harmonic µ
3
 of the MPS spectra of each brain sample 
was normalized to the amplitude µ
3
 of a reference sample of 
known NP content (by iron concentration) measured under 
identical conditions.64
Results
cell labeling and biocompatibility
As expected, our initial experiments showed that Resovist®, 
MCP, and VSOP uptake by MSC increased with incubation 
time (4 hours vs 24 hours, data not shown). We therefore 
continued with a 24-hour protocol, wherein NP uptake was 
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up to three-fold higher in comparison to 4-hour protocols, in 
a particle-dependent manner. The results for 24-hour labeling 
are presented in Figure 1.
Cells incubated with NP for 4 hours and 24 hours showed 
substantial extracellular iron clusters, mostly attached to the 
ECM. Clustering was observed irrespective of the particle 
type, the incubation concentration, or the use of PS as TA. 
Figure 1 shows representative micrographs of cells labeled 
with Resovist®. For meaningful quantification of NP uptake 
into cells, the extracellular NP clusters were significantly 
reduced by ECM disruption with trypsin and cell passage 
(Figure 1C and D). Following ECM disruption, the quanti-
fied averaged NP iron per cell was also reduced but now 
represented the real intracellular NP uptake (Figure 1E). 
Comparison of intracellular NP between cells incubated with 
0.2 mM Resovist® or MCP, alone or with PS, showed that the 
conditions used with PS were ideal to increase intracellular 
uptake of MCP and Resovist® by a factor of ~2.5 and ~1.5, 
respectively (data not shown). However, increasing the NP 
loading concentration to 2 mM was sufficient to avoid the use 
Figure 1 Prussian Blue stain for mesenchymal stem cells labeled with resovist®.
Notes: Incubation at 0.2 mM Fe with protamine sulfate (A). Incubation of resovist® at 2 mM Fe without protamine sulfate (B) resulted in higher NP uptake compared to (A). 
high amounts of extracellular iron are visible after both treatments (A and B). extracellular matrix disruption and passage removed extracellular nanoparticles, allowing 
identification of true NP uptake (C and D). Insets a–d show corresponding images with higher magnification (40×). all scale bars correspond to 500 µm. Quantification of 
average Fe per cell (pg) revealed similar results for Msc labeled with McP and VsOP (E).
Abbreviations: ecM, extracellular matrix; McP, multicore carboxy-methyl-dextran-coated iron oxide nanoparticle; NP, nanoparticle; VsOP, very small iron oxide nanoparticle.
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of PS and resulted in significantly increased intracellular NP 
uptake for both MCP and Resovist® (three-fold and 1.5-fold, 
respectively) and even more significantly for smaller NPs 
such as VSOP, for which a ten-fold uptake was observed 
(Figure 2).
We chose to continue further experiments with highly 
labeled MSC without PS to test the biocompatibility of these 
labeling protocols in comparison with unlabeled cells. Assays 
for PDT, in vitro cell differentiation, CFU-F (Figure 3), and 
MSC marker expression (Figure S1) were performed. Over-
all, PDT assessed for 10 days after NP uptake was similar 
for labeled and unlabeled cells (Figure 3A). Labeled MSC 
showed a similar CFU capacity compared to unlabeled cells 
(Figure 3B). Furthermore, characteristic pluripotent features 
of MSC were not modified by VSOP or MCP labeling. 
Therefore, adipogenic, osteogenic, and chondrogenic differ-
entiation could be similarly induced in labeled and unlabeled 
cells after in vitro stimulation (Figure 3C).
We attempted to label MSC with ferumoxytol (Feraheme®) 
as described by Thu et al,65 but in our hands, no significant 
NP load per cell was achieved after MSC incubation with 
heparin-protamine-ferumoxytol complexes (4 hours + 
overnight [OV] culture) as described. Only an average NP 
load of 0.10 pg Fe per cell vs 0.07 pg Fe per cell for unlabeled 
cells was achieved. In addition, MSC labeled with the heparin-
protamine-ferumoxytol complexes with longer incubation 
time (24 hours) showed an average NP uptake of 0.24 pg 
Fe per cell, and iron detection by Prussian Blue stain was below 
its detection sensitivity (data not shown). We only achieved 
a two-fold increase in Ferumoxytol® uptake per cell (0.54 pg 
Fe per cell to 0.73 pg Fe per cell) after MSC were incubated 
for 24 hours in DMEM plus 1% FBS with Ferumoxytol® at 
4.5 mM Fe and 8.9 mM Fe correspondingly. However, after 
performing ECM disruption and overnight culture, as done 
for MSC in our experiments, to remove unbound NPs, the NP 
load decreased to ~0.22 pg Fe per cell. Taken together, these 
observations suggest that, in the case of ferumoxytol also, 
some of the iron measured after 24-hour incubation under in 
vitro adherent cell conditions and quantified as NP load per 
cell was not intracellular (data not shown).
single-cell MrI in vitro
To assess the contrast effect of cells magnetically labeled with 
Resovist®, MCP, and VSOP, cells were quantified in vitro 
using postprocessed high-resolution phase images, which 
visualize MFMDs caused by the magnetically labeled cells 
when introduced into the magnetic field of the MR scanner. 
T2*-weighted FLASH sequences acquired on a 7 T Bruker 
Pharmascan animal scanner, as described in the “Methods” 
section, were used to image several cell phantoms from dif-
ferent experiments to establish a suitable cell dilution that 
allows single-cell identification. Herein, we show results of 
representative experiments with 2,000 cells and 1,000 cells 
per tube. In addition to labeled cells, controls containing 
unlabeled cells were imaged to ascertain the proportion of 
false-positives primarily caused by air bubbles, which exhibit 
similar dipole figures (Figure 4).
A correlation between the average NP uptake per cell and 
the number of detected cells by MRI was used to determine 
the sensitivity of the 7 T Pharmascan setting used in our 
experiments (Figure 5).
NP uptake per cell correlated with the percentage of 
single cells detected with the 7 T Pharmascan MRI setting 
as used here. Fourteen percent of VSOP-MSC were detected 
in a selected volume of interest when cells were loaded with 
an average of 4 pg Fe per cell. Approximately 28% of cells 
labeled with MCP or Resovist®-MSC were detected when 
average iron uptake reached 6 pg Fe per cell and 9 pg Fe 
per cell, respectively (Figure 5). Furthermore, 43%–45% of 
cells were detected when higher intracellular NP uptake was 
accomplished (VSOP-MSC 21 pg Fe per cell, Resovist®-
MSC 13 pg Fe per cell, and MCP-MSC 17 pg Fe per cell) by 
incubation with 2 mM Fe NP without TA (Figure 5).
Some agarose phantoms imaged on the 7 T Pharmas-
can system were additionally measured on a 7 T BioSpec 
Figure 2 Increasing the NP labeling concentrations was sufficient to increase cellular 
NP uptake, allowing us to avoid use of protamine sulfate.
Notes: cells were loaded at 0.2 mM with resovist® or McP in combination with 
12 µg/ml Ps or VsOP alone (open symbols) and cells loaded at 2 mM without Ps 
for all three NPs (filled symbols). Iron quantification after 24-hour incubation and 
ecM disruption indicates that resovist®-Ps complexes have better uptake by Msc 
than McP-Ps. VsOP show poor uptake at low (0.2 mM) loading concentration. 
however, 10× higher loading concentration (2 mM) in absence of PS was sufficient 
to significantly increase cellular uptake of all NPs. (mean; error bars, ± sD).
Abbreviations: ecM, extracellular matrix; McP, multicore carboxy-methyl-dextran- 
coated iron oxide nanoparticle; NP, nanoparticle; Ps, protamine sulfate; VsOP, very 
small iron oxide nanoparticle.
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(imaging protocol as described in the “Methods” section). 
The higher resolution and the resulting improved signal-to 
noise-ratio (SNR = mean signal/standard deviation of 
background), eg, from 60 with 7 T Pharmascan to 86 with 
7 T BioSpec, resulted in a more than two-fold increase in 
the percentage of cell detection, for Resovist®, MCP, and 
VSOP-MSC (Figure S2).
In vivo MrI of NP-labeled Msc in mouse 
brains
MRI single-cell detection of MSC labeled with Resovist®, 
MCP, and VSOP was performed on murine brains after 
delivery of only 2,000 cells into the CA (Figure 6) and 1,000 
cells for MCP-labeled MSC (Figure S3). The high-resolution 
T2*-weighted FLASH sequences, as described in the 
“Methods” section, allowed detection of MFMDs caused 
by labeled MSC immediately after cell injection for all 
tested NPs, as shown in Figure 6 (total scanning time: 
20 minutes).
Resovist® and MCP-labeled MSC accumulated in the 
left side of the brain (injection side), while the right side was 
free of MFMDs. In comparison, mice injected with VSOP-
MSC showed MFMDs in both hemispheres. This might be 
due to differences in circulation of labeled cells depending 
on the NP used.
To confirm that the detected MFMDs correspond to trapped 
NP-labeled MSC, ex vivo NP quantification on imaged mouse 
brains was conducted by MPS. MPS specifically detects 
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Figure 3 In vitro assays for nanoparticle cell biocompatibility.
Notes: cells labeled with resovist®, McP, or VsOP show similar population doubling time as unlabeled cells (empty) over 10 days (Days 2, 4, 6, and 10 are shown) (mean; 
bars, ± sD; n=3) (A). cells maintained both their mesenchymal stem cell (Msc) character and their self-renewal capacity, showing similar number of colony-forming units 
(cFU) for labeled and unlabeled cells (B). Multipotent differentiation potential (adipogenesis, chondrogenesis, and osteogenesis) of labeled Msc was similar to unlabeled cells 
as shown by Oil red, alcian Blue, and von Kossa stains (C). all scale bars represent 100 µm.
Abbreviations: McP, multicore carboxy-methyl-dextran-coated iron oxide nanoparticle; VsOP, very small iron oxide nanoparticle.
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superparamagnetic iron oxide cores of the NP, and hence, 
neither paramagnetic endogenous iron nor diamagnetic tis-
sue contributes to the MPS signal. Background-free detec-
tion enables highly sensitive NP quantification in tissues or 
organs down to the nanogram range (Figure 6D). MPS particle 
quantification showed that superparamagnetic NPs were only 
detectable on the left side (injection side), while on the right 
side, signals were below the detection limit of 1.1 ng and 
1.3 ng for MCP-labeled and Resovist®-labeled MSC, respec-
tively. In addition, a higher amount of NP iron (13.1 ng) was 
detected in mouse brain injected with MCP-MSC than with 
Resovist®-MSC (6.5 ng), while quantification of VSOP in 
the brain injected with VSOP-MSC failed due to the lower 
sensitivity of MPS for VSOP. Thus, the measurements were 
below a secure detection limit of 5.3 ng.
Discussion
Increasing the sensitivity of MRI can contribute to the monitor-
ing and development of cell therapies. In this study, we present 
Figure 5 MRI quantification of single cells in agarose phantoms and correlation with 
intracellular iron content for cells labeled with resovist®, McP, and VsOP. 
Notes: Increasing iron uptake correlates with increasing MrI detection (mean; 
bars, ± sD; n=4) for single cells. VsOP-Msc average detection increased from 14% 
(4 pg Fe per cell) to 43% (21 pg Fe per cell). resovist®-Msc average detection 
increased from 28% (9.2 pg Fe per cell) to 44% (13 pg Fe per cell) and McP-Msc 
detection from 28% (6 pg Fe per cell) to 45% (17 pg Fe per cell).
Abbreviations: McP, multicore carboxy-methyl-dextran-coated iron oxide nano-
particle; MrI, magnetic resonance imaging, Msc, mesenchymal stem cells; VsOP, 
very small iron oxide nanoparticle.
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Figure 4 Calculation of cell detection ratio by counting magnetic field microdistortions caused by nanoparticle-labeled mesenchymal stem cells embedded in agarose.
Notes: Postprocessed phase images of T2*-weighted Mr images were mainly used to detect cells labeled with resovist® (A), McP (B), and VsOP (C), and empty cells 
(D) at 1,000 cells/ml (A1, B1, and C1) or at 2,000 cells/ml (A2, B2, C2, and D). The upper row shows the MrI magnitude images and the lower row the corresponding 
postprocessed phase images, which allow better discrimination and counting of the single cells. These phase images show the characteristic dipole figures of the cells, which 
correspond to positive phase shifts at the poles and negative phase shifts at the equator (E).
Abbreviations: McP, multicore carboxy-methyl-dextran-coated iron oxide nanoparticle; MrI, magnetic resonance imaging; VsOP, very small iron oxide nanoparticle.
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new MCP and compare them with VSOP and Resovist® for 
MSC labeling and MRI with single-cell sensitivity.
Labeling MSC with ferumoxytol (Feraheme®), as 
described by Thu et al65 (average NP load with $2.2 pg Fe per 
cell),65 was not successful in our hands and did not result in a 
significant NP load per cell. This poor uptake of ferumoxytol, 
as also the uptake reported by other authors,28–30 might not 
be sufficient to achieve single-cell detection by MRI as dis-
cussed in this report. Therefore, we chose MCP, VSOP, and 
Resovist® to accomplish single-cell detection by MRI.
Optimized cell culture conditions and NP-labeling pro-
tocols with reliable characterization are required to help 
advance cell MRI. The protocol presented here is the result 
of careful standardization with BM MSC (Thermo Fisher Sci-
entific). Factors such as cell synchronization and cell density 
significantly affect NP uptake (as illustrated in Figure S4), 
which emphasizes the relevance of standardization when 
using different cell types.
In addition, strong NP adherence to surface-activated 
polystyrene cell culture material was observed after 24-hour 
incubation of NPs without cells (retention of ~75% [Fe] for 
VSOP and ~25% [Fe] for MCP or Resovist® by the plastic 
flasks). This NP adherence was also observed in presence of 
MSC, which produced large amounts of ECM. Therefore, spe-
cial care is required in performing downstream iron staining 
and NP uptake quantification, and the results must be inter-
preted with caution. For instance, unbound and ECM-bound 
NPs are not completely removed by PBS washes (3×) and 
centrifugation, as carried out for standard cell collection, and 
might result in erroneous determination of NP Fe per cell.
Reduction of extracellular NPs is essential for the correct 
interpretation of downstream cell toxicity assays66,67 and for 
improving MRI single-cell detection, because extracellular 
NPs will be most probably lost during cell migration.
After ECM disruption and overnight cell recovery in new 
adherent culture plates, we observed a significant reduction 
Figure 6 MrI detection at 7 T of mesenchymal stem cells in mouse brain after carotid injection of 2,000 NP-labeled cells.
Notes: Improved visualization of magnetic field microdistortions in phase images (lower row) vs magnitude images (upper row) is observed for all NP-labeled MSC. Single 
microdistortions correspond to Msc labeled with resovist® (A), McP (B), and VsOP (C). cells are visualized in the left hemisphere (supine position), while the right side is 
mostly free of cells and served as background control. Superparamagnetic iron quantification by MPS (D) confirmed that MRI signal was specific to NPs in the left hemisphere 
of mice injected with resovist®-labeled (6.5 ng) and McP-labeled Msc (13.1 ng), while corresponding right hemispheres had no signal for NPs, and total NP amount in brain 
(C) was too small to be detected (out of range).
Abbreviations: McP, multicore carboxy-methyl-dextran-coated iron oxide nanoparticle; MPs, magnetic particle spectroscopy; Or, out of range; NP, nanoparticle; 
VsOP, very small iron oxide nanoparticle.
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of NPs adhering to plastic flasks and extracellular iron for 
all NPs investigated here. Intracellular NPs are shown as 
perinuclear iron by Prussian Blue stain (Figure 1). We also 
confirmed the intracellular localization of VSOP and MCP 
by transmission electron microscopy (TEM) (Figure S5). 
Overall, we could standardize a protocol for intracellular 
labeling of MSC using our MCP and VSOP with and without 
TA, thereby removing extracellular NP.
Although the cellular routes of MCP and VSOP internal-
ization are beyond the scope of this report, differences in the 
characteristics of the NPs used here (Table 1 and Figure S6) 
need to be discussed. NP coating and surface charge (zeta 
potential) influence not only NP stabilization but also their 
interaction with cell membrane components and proteins 
such as FBS, a component of incubation media. Additionally, 
interactions between NP coatings and extracellular proteins 
such as FBS might result in NP protein coronas that modify 
their hydrodynamic size and surface properties and therefore 
influence their cellular uptake.12,68
Resovist® and MCP are sterically stabilized with the 
sugar polymers carboxydextran and carboxymethyldextran, 
respectively, and thus are very similar to each other. The 
additional carboxymethyl groups in carboxymethyldextran 
account for the difference in surface charge (zeta poten-
tial) of MCP (−38.8 mV) and Resovist® (−25.1 mV). In 
contrast, VSOP are electrostatically stabilized with citrate 
molecules and have a zeta potential value of −39.8 mV. The 
negative surface charge of VSOP and their small particle 
diameter result in a higher surface energy, which explains 
the observed stronger affinity of VSOP to cell culture dish 
surfaces pretreated to improve cell adhesion (chemically 
modified and positively charged polystyrene or poly-D-
lysine-coated surfaces). In the case of Resovist® and MCP, 
electrostatic attraction to positively charged surfaces is 
reduced by steric repulsion of the polymer coating. This 
is in concordance with higher NP binding after 24 hours’ 
incubation (2 mM) for VSOP in comparison with Resovist® 
(Figure 1E).
Biocompatibility is an essential property of contrast 
agents developed for cell labeling. We are aware that even 
when most cells are labeled (.90%), NP uptake highly dif-
fers from cell to cell, as later discussed. Thus, downstream 
assays for testing NP biocompatibility are performed with 
nonhomogeneous cell populations and represent net effects. 
Downstream biocompatibility assays with cell populations 
showing narrow distribution of NP uptake are needed to 
address concerns about NP cell toxicity.
We performed assays similar to other investigators for 
comparison and therefore only report biocompatibility assays 
of cells with high averages of internalized NPs. Therefore, the 
effect of labeling with MCP (average NP uptake: 17 pg Fe 
per cell) and VSOP (average NP uptake: 21 pg Fe per cell) 
(Figure 2) was tested on MSC and compared with unlabeled 
(empty) cells. Biocompatibility of Resovist® has been shown 
before.69
In general, labeling with MCP and VSOP results in 
similar PDT compared with unlabeled cells over 10 days. 
However, because the NP load is diluted over time, this 
assay reflects a realistic NP effect on MSC proliferation 
until Day 6. Characteristically, cells labeled with Resovist® 
had a 1.8 times higher PDT than empty cells (Figure 3A). 
An effect of free iron released from lysosomal degradation 
on cell cycle progression has been suggested for human 
MSC after Resovist® exposure.70 The release of free iron 
over longer periods of time would need to be tested for 
MCP and VSOP under undiluted conditions. Nevertheless, 
MSC proliferation until Day 6 was not influenced by MCP 
or VSOP under the experimental conditions used here.
Further assays revealed no significant effect of MCP or 
VSOP on in vitro MSC self-renewal potential (Figure 3B) 
or multilineage differentiation (Figure 3C).
Despite the expected dilution of NPs over time,71 the 
applied differentiation protocols do not allow much cell divi-
sion, and iron was still detectable after differentiation proto-
cols were completed (2–3 weeks), as seen by double-positive 
stain for iron and adipogenesis- or chondrogenesis-induced 
Table 1 analytical properties of the nanoparticles used in our experiments
Measured in Water (formulated NPs) 10 mM NaCl
(unformulated NPs)
T1-relaxivity  
R1 (mM
−1s−1)
T2-relaxivity  
R2 (mM
−1s−1)
Hydrodynamic size  
(nm) by number
PDI Z-potential (ζ)
(mV)
Ferucarbotran (resovist®) 13 142 24.4–43.8 0.195 −25.1 (ph: 7.17)
Multicore particles (McP) 13 290 28.2–43.8 0.203 −32.8 (ph: 7.22)
VsOP 19 53 8.7–13.5 0.106 −39.8 (ph: 7.23)
Abbreviations: PDI, polydispersity index; NP, nanoparticle; McP, multicore carboxy-methyl-dextran-coated iron oxide nanoparticle; VsOP, very small iron oxide 
nanoparticle.
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cells (Figure 3C). This confirms active differentiation of 
cells loaded with NPs.
The effect of Resovist® on MSC osteogenic differentia-
tion is controversial, and observations ranging from complete 
osteogenesis inhibition,72 to a dose- and MSC-origin-dependent 
effect,61 to no effect69 have been reported. However, direct 
comparison of these results is difficult because they are based 
on different amounts of intracellular NPs.
In our hands, VSOP- and MCP-labeled MSC remained 
adherent throughout the time required for osteogenesis and 
stained positive with von Kossa stain after induced osteo-
genesis differentiation. However, alizarin red stain and 
osteogenic gene expression should be analyzed before using 
VSOP-MSC or MCP-MSC in regenerative animal models, 
in which their osteogenic capacity is required.
single-cell MrI in vitro
As shown for the NPs investigated here, the detection rate of 
single cells depends on NP T2 relaxivity (R2), the amount 
of internalized NPs per cell, the MRI protocol, and scanner 
specifications. Intracellular NPs are usually clustered in 
organelles (phagolysosomes), which can increase the MRI 
contrast effect in the presence of high NP accumulation.73 
In our experiments, with sufficient cell dilution, single MSC 
labeled with VSOP, Resovist®, or MCP could be identified 
by their MFMDs with high-resolution MRI. These MFMDs, 
which locally alter the proton resonance frequencies,52 are 
visible as the signal decreases in MRI magnitude images but 
are especially conspicuous in postprocessed phase images, 
which reveal the positive and negative resonance frequency 
shifts (Figure 4).
Moreover, an increased average amount of intracellular 
NP increased the percentage of detected cells for all tested 
NPs. In addition, cells labeled with NPs with high R2 such 
as MCP or Resovist® required less iron uptake for similar 
MRI detection than cells labeled with VSOP, which have 
a smaller R2 (Table 1 and Figure 5). Nevertheless, higher 
uptake of VSOP compensated for the lower R2 and resulted 
in comparable sensitivity for single MSC (Figure 5). Thus, 
all three NPs investigated here seem suitable for sensitive 
MSC detection by MRI. Further applications and advantages 
of using MSC and other cells labeled with VSOP or MCP 
need to be explored. Results emerging from the ongoing 
development of magnetic particle imaging (MPI) suggest 
that particle aggregation as observed for Resovist® might be 
advantageous for optimal MPS/MPI signal.74 Consequently, 
multicore particles such as MCP have been developed for 
MPI and require further investigation of how the MPI signal 
is affected when MCP cluster in cells. Advantages of combin-
ing MRI anatomical information with MPI sensitivity and 
quantification have been outlined by Kratz et al.75 Therefore, 
cell labeling for single-cell detection by MRI, as carried out in 
this study, could make an important contribution to improve 
cell tracking when combined with MPI.
Micrograph quantification of iron-positive cells showed 
that 80%–90% had intracellular NPs. However, measurement 
of blue areas per cell was highly variable (data not shown), 
indicating high heterogeneity of NP load per cell, as is also 
apparent in Figure 1. This could explain why only 50% of 
the labeled cells contained enough NPs to be detected with 
the 7 T Pharmascan MRI setup.
Later, experiments with a recently available 7 T BioSpec 
scanner improved image quality and allowed the visualiza-
tion of single cells with smaller MFMDs (lower NP load 
per cell) (Supplementary materials). Therefore, detection 
of cells with a given NP load can be increased using more 
advanced MRI equipment. Nevertheless, because intracel-
lular NP uptake is dependent on the cell’s surface area,36,76 
the high variability of NP load among cell populations 
remains a problem to be solved, eg, by using magnetic cell 
separation techniques.
single-cell MrI in vivo
All three NPs investigated here allowed clear visualization of 
MFMDs of the labeled MSC in postprocessed phase images 
obtained by 7 T Pharmascan MRI (Figures 6 and S3). Cell 
transfer into the mouse brain via the CA required standard-
ized injection volumes to acquire MRI scans with comparable 
numbers of entrapped cells before the cells were washed out 
by the blood stream. Although no other tissues in the brain 
have such a high magnetic susceptibility as NP-labeled cells, 
large blood vessels perpendicular to the imaging plane can 
cause magnetic distortions that appear similar to MFMDs 
in a single imaging slice; however, they are easily distin-
guishable from labeled cells by comparison with adjacent 
imaging slices. Furthermore, in the magnitude images, the 
signal loss of blood vessels is lower than that of the labeled 
cells (Figure S3).
Ex vivo quantification of magnetic iron by MPS and by 
comparison of the left and right brain hemispheres confirmed 
that the MRI signal was caused by labeled MSC. Using MPS, 
we estimated the amount of MSC entrapped in the brains 
to be ~700 MCP-labeled MSC (18 pg Fe per cell) and 500 
Resovist®-labeled MSC (13 pg Fe per cell).
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Overall, we believe that high-resolution MRI with single-
cell sensitivity and MPS iron quantification are useful tools 
to optimize and standardize cell delivery parameters and 
overcome one of the key challenges of cell therapy.
We observed that Resovist®- and MCP-labeled MSC 
were in general more “sticky” in adherent cell culture 
conditions and were also better retained in brain capillaries 
than VSOP-MSC for the time required between injection 
and tissue collection (~1 hour). Therefore, we speculate 
that these observations might be attributable to the different 
effects of labeling with MCP or VSOP on cell adherence. 
Further experiments in different setups should be conducted 
to explore the effect of VSOP- vs MCP-labeled cells on cell 
migration or tissue engraftment.
Conclusion
In summary, we assessed the suitability of VSOP and 
new MCP for MRI of MSC with high sensitivity. For this 
purpose, we standardized an in vitro protocol for intracel-
lular labeling of MSC with high NP load (iron average 
per cell .10 pg Fe per cell) without the use of TAs. This 
protocol allowed detection of MSC labeled with VSOP, 
MCP, and Resovist® with single-cell sensitivity by their 
MFMDs in agarose phantoms and in vivo in mouse brains 
using a 7 T animal scanner. Additionally, we point out that 
high amounts of NPs adhere to positively charged plastic 
surfaces, which are commonly used to culture adherent cells 
and which need to be removed for accurate quantification 
of internalized NPs.
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Figure S1 Mesenchymal stem cell surface marker expression.
Notes: Msc surface marker expression for cells without nanoparticles (empty cells: dotted gray line histograms) is similar to that of VsOP-labeled cells (continuous black 
line). In addition, histograms for VSOP-labeled cells without staining for MSC surface markers (broken gray line) show low fluorescent background.
Abbreviations: Msc, mesenchymal stem cells; VsOP, very small iron oxide nanoparticle; aPc, allophycocyanin; FITc, Fluorescein Isothiocyanate; Pe, Phycoerythrin.
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Figure S2 agarose phantom of labeled Msc imaged on 7 T Biospec vs 7 T Pharmascan MrI (Bruker).
Notes: MrI of agarose phantoms using a Bruker Biospec MrI scanner with cryoProbe (A1–D1) has higher resolution and improves the signal-to-noise ratio (sNr: 86) in 
comparison to 7 T Pharmascan MrI (sNr: 60) (A2–D2). Hence, the detection of magnetic field microdistortions caused by NP-labeled MSC in postprocessed phase images 
was improved, and the percentage of quantified single cells was two- to three-fold higher for the 7 T BioSpec. The Biospec MRI scanner has recently become available to us, 
and these results promise improvements for MrI with single-cell sensitivity in future in vivo experiments.
Abbreviations: 7 T, 7 Testla; McP, multicore carboxy-methyl-dextran-coated iron oxide nanoparticle; MrI, magnetic resonance imaging; Msc, mesenchymal stem cell; 
NP, nanoparticle; VsOP, very small iron oxide nanoparticle.
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Figure S3 MrI detection at 7 T of Msc in mouse brain after carotid injection of McP-labeled cells.
Notes: Magnitude (A1–C1) and phase images (A2–C2) of mouse brain before injection (A), after injection of nonlabeled cells (B), and after injection of 1,000 McP-labeled 
Msc (C). Msc trapped in blood vessels of the left hemisphere are visible as signal reductions in the magnitude image (C) and as dipole figures in the phase image (MFMD) 
(C2). (Flash gradient-echo sequence, 80 µm in-plane resolution, slice thickness 300 µm, Te 5.4 milliseconds, Tr 400 milliseconds).
Abbreviations: MRI, magnetic resonance imaging; MCP, multicore superparamagnetic nanoparticles; MSC, mesenchymal stem cells; MFMD, magnetic field microdistortion; 
Te, echo time; Tr, repetition time.
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Figure S5 example to illustrate the intracellular uptake of VsOP and McP by Msc by TeM.
Notes: Msc were incubated with nanoparticles (2 mM) for 24 hours, followed by washing steps and extracellular matrix removal (24 hours + ecM) as described in 
“Methods” section. NP clustering engulfed by phagolysosomes proves intracellular uptake for VsOP and McP. all scale bars correspond to 100 nm.
Abbreviations: ecM, extracellular matrix; McP, multicore superparamagnetic nanoparticles; Msc, mesenchymal stem cells; NP, nanoparticle; TeM, transmission electron 
microscopy; VsOP, very small iron oxide nanoparticles.
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Figure S4 effect of cell density, nanoparticle concentration, and ratio of NP to protamine sulfate on NP uptake by Msc.
Notes: Msc at variable cell densities were labeled with McP in combination with protamine sulfate (Ps) at different ratios and stained for iron using the Prussian Blue stain 
protocol. cell incubation with increasing NP concentration with and without Ps (25:0) increased cellular NP uptake for Msc at 15,000 cells/cm2. Increasing cell density 
caused high extracellular matrix and high NP aggregation when incubated with McP-Ps complexes as observed for 40,000 cells/cm2 with McP-Ps at ratios of 10:12 and 
25:30. However, cell recovery was decreased after MSC incubation with high PS concentration (25:30). Overall, more efficient cellular recovery and cellular NP uptake were 
achieved when Msc were cultured at 15,000 cells/cm2 and incubated with McP-Ps complexes at 10:12 ratio or with high NP concentration but without Ps (25:0).
Abbreviations: Msc, mesenchymal stem cells; McP, multicore superparamagnetic nanoparticles; Ps, protamine sulfate; NP, nanoparticle.
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Figure S6 Nanoparticle TeM study.
Notes: Nanoparticle size and morphology were analyzed by hrTeM using a TecNaI g2 20 s-Twin (FeI-company, hillsboro, Or, Usa). TeM samples were prepared by 
coating copper grids with diluted nanoparticle solutions.
Abbreviations: TeM, transmission electron microscopy; hrTeM, high-resolution transmission electron microscopy.
5HVRYLVW 0&3 9623
QPQPQP
